Full-Time

Senior ML Engineer

Posted on 11/1/2025

Deadline 1/1/26
Evolent

Evolent

1,001-5,000 employees

Delivers value-based care through analytics

No salary listed

Pune, Maharashtra, India

Remote

Category
AI & Machine Learning (2)
,
Required Skills
Scikit-learn
Microsoft Azure
Agile
Python
Data Science
Tensorflow
Git
Keras
Pytorch
Apache Spark
SQL
Machine Learning
AWS
Pandas
NumPy
DevOps
Requirements
  • Bachelor’s Degree in Computer Science, Machine Learning, Data Science, or a related field
  • 7+ years of Proficiency in Python for constructing data pipelines, and using ML frameworks and libraries such as Keras, PyTorch, Scikit-Learn, TensorFlow, and XGBoost
  • Expertise in statistical methods, data structures, algorithms, feature engineering, transformations, and data mining
  • 5+ years advanced experience in SQL, including experience writing new and efficient SQL queries for complex analytical tasks
  • 5+ years of experience developing in a cloud environment (AWS, GCS, Azure)
  • 5+ years of experience with Github, Github Actions, CI/CD, and source control
  • 5+ years working within an Agile environment
  • Passion for solving problems within healthcare that have tangible impacts on healthcare operations and patient lives
  • Excel in solving ambiguous and complex problems, being able to navigate through uncertain solutions, breaking down complex challenges into manageable components, and developing innovative solutions
Responsibilities
  • Design, develop, and deploy advanced machine learning models and algorithms to primarily improve the performance of our prior authorization platforms
  • Construct advanced SQL queries, perform preprocessing, feature engineering, and transformations to analyze healthcare data and ensure high quality input for model training
  • Collaborate with Product and Engineering teams to integrate and deploy ML models into development and production environments, spread across various locations in the US and India
  • Work closely with clinicians and stakeholders to drive the development, efficacy, and improvement of our ML models
  • Work with Infrastructure and Architecture teams to drive model efficiency, reliability, and scalability
  • Leverage Azure DevOps for continuous integration and continuous deployment (CI/CD) of ML models
  • Lead Machine Learning Operations (MLOps) to streamline the process of bringing a machine learning model into production, maintain, monitor, and identify opportunities for improvement
  • Perform data mining as necessary to uncover insights, drive decision-making, and determine best channel approaches to drive automation across our platforms
  • Implement feature flagging to rapidly pilot model enhancements, exception handling, and performance optimization
  • Translate complex technical details into clear, actionable insights for stakeholders by telling stories through data
  • Stay current with the latest advancements in ML and AI; testing and integrating new techniques into existing applications
  • Mentor and guide junior engineers, fostering a culture of continuous learning and improvement
Desired Qualifications
  • Master’s Degree or Ph.D. in Computer Science, Machine Learning, Data Science, or a related field
  • Healthcare experience, particularly using administrative and prior authorization data
  • Proven experience with developing and deploying ML systems into production environments
  • Proficiency using Azure cloud-based services and infrastructure, Azure ML Studio, and Azure MLOps
  • Experience working with Product, Engineering, Infrastructure, and Architecture teams
  • Experience with deep learning, reinforcement learning, NLP, and LLMs
  • Experience with feature flagging
  • Publications or contributions to the machine learning community

Evolent Health helps healthcare organizations transition to value-based care by pairing technology, analytics, and clinical expertise to improve patient outcomes while lowering costs. It partners with health systems, physician groups, and health plans to deliver data-driven care coordination, population health management, and risk-adjustment services. The company’s offerings include software platforms, analytics, and clinical support that enable more efficient care delivery, shared savings programs, and performance-based incentives. Compared with competitors, Evolent emphasizes end-to-end collaboration with clients and a diversified client base, combining technology with hands-on clinical and operational expertise to drive measurable outcomes. Its goal is to help clients succeed in value-based models by delivering better patient care at lower total costs.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Arlington, Virginia

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Oncology launches with Highmark and Aetna drive $2.4-2.6B 2026 revenue guidance.
  • Performance Suite expansion generates over $200M annual revenue from new agreements.
  • Archie Mayani's 2026 appointment accelerates AI in prior authorizations and clinical support.

What critics are saying

  • 7x leverage and $398M Q4 2025 goodwill impairment trigger covenant breaches by mid-2027.
  • Q1 2026 6.9% revenue miss erodes confidence, limits capital access post-$145M notes.
  • Privia Health's 17.4% Q4 growth captures share as Evolent posts flat $468.7M revenue.

What makes Evolent unique

  • Evolent unifies oncology, cardiology, musculoskeletal solutions under single platform post-2023 rebrand.
  • Serves 41 million enrollees with clinician-led pathways and technology-enabled decision support.
  • Focuses exclusively on value-based specialty care after divesting primary care to Privia in 2025.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Hybrid Work Options

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
Yahoo Finance
Mar 19th, 2026
Evolent appoints Archie Mayani as chief product officer to drive AI innovation in healthcare

Evolent Health has appointed Archie Mayani as chief product officer. Mayani brings over 20 years of experience in healthcare technology and AI innovation from roles at GHX, Change Healthcare, UnitedHealth Group and Amazon. Most recently, Mayani served as CPO at GHX, where she developed AI-powered capabilities for healthcare supply chains. At Change Healthcare, she led clinical decision support and revenue cycle platforms, focusing on reducing administrative burden in prior authorisation. During her time at Optum and UnitedHealth Group, she scaled value-based care programmes that improved Medicare STARS performance and reduced hospital utilisation. Mayani also served as global head of product and content operations for Amazon Prime Video. She has received multiple industry honours, including the Global CPO Award in 2025 and Inspiring Leader Award in 2023.

Yahoo Finance
Mar 7th, 2026
Evolent Health drops to $5.18 fair value on 7x leverage and $398M goodwill impairment

Evolent Health faces a shifting investment narrative after analysts reset expectations, with fair value estimates dropping from $8.50 to $5.18. The revision reflects concerns about reserves, leverage and margin visibility. Despite lowered price targets, Oppenheimer, BTIG, UBS, Citi, Truist and Canaccord maintain positive ratings, citing conservative reserving and new contracts as potential margin support. Analysts view new CFO Mario Ramos as bringing increased transparency. However, KeyBanc downgraded to Sector Weight, highlighting leverage at approximately 7x and limited EBITDA recovery visibility. Multiple firms reduced 2026-2028 earnings assumptions amid medical cost pressures and ACA exchange membership concerns. Evolent recorded a $398 million goodwill impairment for Q4 2025 and issued 2026 revenue guidance of $2.4 billion to $2.6 billion.

Yahoo Finance
Feb 25th, 2026
Evolent Health shares jump 20.7% on Q4 beat and strong 2026 revenue guidance

Evolent Health shares surged 20.7% after the healthcare solutions company reported fourth-quarter earnings that beat expectations and issued optimistic revenue guidance. The company posted non-GAAP earnings of $0.08 per share, significantly improved from a $0.02 per share loss a year earlier and ahead of analyst forecasts. Whilst quarterly revenue fell 27.5% year-on-year to $468.7 million, meeting expectations, investors focused on strong future guidance. Evolent projected full-year 2026 revenue between $2.4 billion and $2.6 billion, with the midpoint suggesting approximately 30% growth and nearly 5% above analyst estimates. The shares are trading at $3.15, down 19.2% year-to-date and 73.3% below their 52-week high of $11.79 from July 2025.

Pulse Nigeria
Sep 24th, 2025
Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care

Privia Health acquires Evolent's ACO business to boost value-based care.

Healthcare Dive
Sep 24th, 2025
Privia acquires Evolent's value-based primary care unit for $100M

Privia Health is acquiring a value-based primary care business from Evolent Health as the physician enablement company continues to expand its care delivery network into new geographies.

INACTIVE